Drug Database
Back to search

Netherlands· NL-25133ff14fb9

Nystatine RPH 100.000 IE/ml, suspensie voor oraal gebruik

A nystatin product containing nystatine, registered in Netherlands by RPH Pharmaceuticals AB. The same ATC class is registered in 13 of our 19 countries.

ATC A07AA02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedNystatine RPH 100.000 IE/ml, suspensi…ATCA07AA02REGISTER NO.NL-25133ff14fb9PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about nystatineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nystatin is registered in 13 of 19 countries.

Countries holding a registration under ATC A07AA02 (nystatin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search nystatin products by name

Nystatin · ATC A07AA02

13 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
NYSTATINE
Manufacturer
RPH Pharmaceuticals AB
Country
Netherlands (NL)
ATC code
A07AA02
ATC class
Nystatin
Defined daily dose
1.5 MIO, E
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    121827

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

436 interactions on record for nystatin.

Graded by severity as the source publishes them — 436 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check nystatin against other medicinesHow interaction checks work

Nystatin · interactions on record

436 records

  • 436 info

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Nystatin in 16 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All nystatin products

    Authorised across Europe · EMA

    The same active substance is authorised in 26 EEA countries. Names it is sold under:

    • Austria · Candio, Mycostatin
    • Belgium · Nilstat, Skandyra
    • Bulgaria · Нистатин Абр, Нистатин Актавис
    • Cyprus · Nystamysyn, Restatin
    • Czechia · Fungicidin Léčiva
    • Germany · Adiclair, Biofanal
    • Denmark · Nystatin Orifarm, Nystimex
    • Spain · Mycostatin
    • Finland · Nystatin Orifarm, Nystimex
    • France · Mycostatine
    • United Kingdom (Northern Ireland) · Nystan, Nystatin Vygoris
    • Greece · Nystamysyn
    • Croatia · Pronigyn
    • Hungary · Nystatin Pannonpharma
    • Ireland · Mycostatin (Ready Mixed)
    • Iceland · Nystatin Orifarm, Nystimex
    • Italy · Mycostatin
    • Lithuania · Nystatin Actavis
    • Luxembourg · Biofanal Kombi, Candio-Hermal
    • Norway · Nystatin Orifarm, Nystimex
    • Poland · Nyscandin, Nystapol
    • Portugal · Mycostatin
    • Romania · Nistatina Atb, Nistatină Atb
    • Sweden · Nystatin Evolan, Nystatin Orifarm
    • Slovenia · Pronigyn
    • Slovakia · Fungicidin Léčiva, Nystatin Galvex

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/f1fd588f-488a-4d48-bcb1-6cf8bc6064b5
GET /v1/drugs/f1fd588f-488a-4d48-bcb1-6cf8bc6064b5?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "form": "Suspensie voor oraal gebruik",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h121827_smpc.pdf",
  "strength": null,
  "atc_label": "Nystatin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg121827",
  "excipients": [
    "CARMELLOSE NATRIUM (E 466)",
    "METHYLPARAHYDROXYBENZOAAT (E 218)",
    "PEPERMUNTOLIE",
    "WATER, GEZUIVERD",
    "XYLITOL (E 967)"
  ],
  "substances": [
    "NYSTATINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h121827.pdf",
  "authorised_at": "2017/11/27",
  "procedure_number": "SE/H/1366/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "121827",
  "additional_monitoring": "N"
}
    API referenceMCP serverPlans

    See everything about nystatin.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console